Article | April 17, 2026
9th Circuit Tells USDA to Rework Bioengineered Food Disclosure Standard
Read More
Article | April 13, 2026
FDA Approves New Oral GLP-1 as Scrutiny of the Market Intensifies
Read More
Article | April 09, 2026
FTC Turns Up the Heat on Healthcare: Key Implications for Medtech, Pharma, & Biotech Companies
Read More
Article | April 07, 2026
OIG Advisory Opinion 25-11: Key Compliance Insights for Manufacturers
Read More
Article | April 02, 2026
CDS Software Final Guidance Carries Real Consequences for Manufacturers
Read More
Article | March 24, 2026
OPDP’s 2026 Untitled Letters: Early Enforcement Trends in Prescription Drug Promotion
Read More
Article | March 19, 2026
Enforcement Discretion for “No Artificial Colors” Food Labeling Claims
Read More
Article | March 05, 2026
Event Recap: Negotiating Medical Device, Pharmaceutical, and Biotechnology Product Sales Contracts
Read More
Article | February 23, 2026
Prepare for Impact: CCPA Risk Assessment Regulations Now in Effect
Read More
Article | February 18, 2026
A Recent Challenge to FDA’s Approach to Dietary Supplements Claims
Read More
Article | February 17, 2026
Sunshine Reporting Season Has Begun: Are You Meeting the Requirements?
Read More
Article | February 10, 2026